Full Committee Hearing The Cost of Prescription Drugs: How the Drug Delivery System Affects What Patients Pay, Part II

Date: Tuesday, October 17, 2017 Time: 10:00 AM Location: 430 Dirksen Senate Office Building

Open in New Window

Witnesses

  1. Lori M. Reilly
    Executive Vice President
    Policy, Research & Membership, Pharmaceutical Research and Manufacturers of America
    Washington, D.C.
  2. Chester “Chip” Davis, Jr.
    President and Chief Executive Officer
    Association for Accessible Medicines
    Washington, D.C.
  3. Elizabeth A. Gallenagh
    Senior Vice President Government Affairs and General Counsel
    Healthcare Distribution Alliance
    Arlington, VA
  4. Mark Merritt
    President and Chief Executive Officer
    Pharmaceutical Care Management Association
    Washington, D.C.
  5. Thomas E. Menighan, BSPharm, MBA, ScD(Hon.), FAPhA
    Executive Director and Chief Executive Officer
    American Pharmacists Association
    Washington, D.C.

Related Photos